[Analysis of prognostic factors of non-small cell lung cancer in patients under 40 years of age]

Zhonghua Zhong Liu Za Zhi. 2012 Sep;34(9):703-5. doi: 10.3760/cma.j.issn.0253-3766.2012.09.013.
[Article in Chinese]

Abstract

Objective: To investigate the prognostic factors for non-small cell lung cancer(NSCLC)in patients under 40 years of age.

Methods: The clinicopathological data of 148 young patients with NSCLC were retrospectively analyzed. Kaplan-Meier and Cox regression analyses were used to analyze the relationship between prognostic factors and survival time.

Results: The patients were followed-up for 6 - 148 months, and the follow-up rate was 100%. In the whole group, 122 patients died and 26 cases were surviving. The 1-, 3- and 5-year survival rates were 54.7%, 10.4% and 5.6%, respectively. The median survival time (MST) was 14.7 months. Kaplan-Meier analysis showed that Karnofsky performance status (KPS), clinical stage, treatment modality and serum CEA were related with prognosis (P < 0.05). Multivariate analysis indicated that KPS, clinical stage, treatment modality and serum CEA were independent prognostic factors (P < 0.05).

Conclusions: KPS, CEA, clinical stage and treatment modalities are independent prognostic factors in young NSCLC patients.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoembryonic Antigen / blood*
  • Carcinoma, Non-Small-Cell Lung* / blood
  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Carcinoma, Non-Small-Cell Lung* / pathology
  • Carcinoma, Non-Small-Cell Lung* / radiotherapy
  • Carcinoma, Non-Small-Cell Lung* / surgery
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Karnofsky Performance Status
  • Lung Neoplasms* / blood
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / pathology
  • Lung Neoplasms* / radiotherapy
  • Lung Neoplasms* / surgery
  • Male
  • Neoplasm Staging
  • Pneumonectomy* / methods
  • Proportional Hazards Models
  • Retrospective Studies
  • Survival Rate
  • Young Adult

Substances

  • Carcinoembryonic Antigen